Meissa Vaccines signs CGMP manufacturing agreement for RSV vaccine

Meissa Vaccines, a clinical-stage biotech company developing vaccines to prevent viral respiratory infections, has entered into a manufacturing agreement with contract research development organization (CRDMO) Exothera.

Related Keywords

United States ,Jumet ,Waals Gewest ,Belgium ,Meissa Attenublock ,Frank Glavin ,Meissa Vaccines ,